Everolimus-eluting vs. paclitaxel-eluting coronary stents in the treatment of small vessels: pooled results of the SPIRIT III and SPIRIT IV randomized clinical trials through 2 years

Nov 16, 2017 by in CARDIOLOGY Comments Off on Everolimus-eluting vs. paclitaxel-eluting coronary stents in the treatment of small vessels: pooled results of the SPIRIT III and SPIRIT IV randomized clinical trials through 2 years

Background Higher rates of adverse cardiac events have been observed in patients with small vessel disease. In a pooled analysis of the SPIRIT III and IV trials, we compared an…

read more

Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté vs. TAXUS Express stents in small vessel coronary stenting

Nov 16, 2017 by in CARDIOLOGY Comments Off on Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté vs. TAXUS Express stents in small vessel coronary stenting

Background Advanced stent platform iterations should be able to demonstrate safety and efficacy advantages over earlier-generation devices while being cost-effective. We developed an economic model to evaluate cost-effectiveness of stent…

read more

Understanding the impact of drug-eluting stent on vascular function and the nitric oxide pathway genes using a pig coronary artery stent implantation model

Nov 16, 2017 by in CARDIOLOGY Comments Off on Understanding the impact of drug-eluting stent on vascular function and the nitric oxide pathway genes using a pig coronary artery stent implantation model

Objective Drug-eluting stents (DES) are known to impact vascular functions. The impact of the polymers and the drugs used in DES on the pathways regulating vascular reactivity is not well…

read more

Impact of diabetes mellitus on clinical outcomes of patients with end-stage renal disease undergoing percutaneous coronary intervention

Nov 16, 2017 by in CARDIOLOGY Comments Off on Impact of diabetes mellitus on clinical outcomes of patients with end-stage renal disease undergoing percutaneous coronary intervention

Background The presence of end-stage renal disease (ESRD) after percutaneous coronary interventions (PCIs) is associated with poor outcomes, but the specific contribution of diabetes mellitus (DM) is not established. Methods…

read more
Get Clinical Tree app for offline access